Products
Custom Model Solutions
Pharmacology Services
In vivo PD evaluations
EX Vivo Pharmacological Assays
Pathological / Toxicological Assays
In Vitro Pharmacology
Activities
News
Promotions
Events
Webinars
Blogs
Resources
Download center
FAQs
Health Report
About Shipment
External resources
About Us
Contact Us
Cart
Humanized Models
Immune-Related Mice
Toolbox of Mice
Genetically Edited Rats
Supporting services
Cell lines
Other Products
Tumor Targets
Immune Checkpoints
Complements
Cytokines
Cytokine Receptors
Metabolic Targets
Viral Infection Receptors
Other Targets
Immunodeficient
Humanized Drug Targets
Cytokine Reporters
Inducible Cell Ablation
Cell-specific Reporter
Fluorescent & Other Reporters
Reporters
Find Cre
Tet-regulated
CRISPR/Cas knockins
Reporters
Cre-drivers
Immunodeficient
Humanized Drug Targets
Diseases
Model breeding
Breed conservation service
Reporter-labeled
Primary cell lines
Wild-Type
Humanized Drug Targets
Others
Manual Nucleic acid extraction kits
Automated Nucleic Acid Purification Solution
Protein Affinity Resins
Antibody Affinity Resins
Home
/
Genome editing with CRISPR/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome
Genome editing with CRISPR/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome
Inquires
Gene Summary
Gene Name
Model Description
-
Order Form
Please fill in the order form and we will contact you within 2 working days.
h4-1BB(2)
NM-HU-190077
1
First Name*
Last Name*
Organization*
Email*
Phone
Contact
Back to top
